Clincosm LogoSign in Get a demo

Cardiac SPECT With Rotating Slant Hole Collimator

Sponsor
Johns Hopkins University (Other)
Overall Status
Completed
CT.gov ID
NCT00328315
Collaborator
National Institute for Biomedical Imaging and Bioengineering (NIBIB) (NIH)
5
Enrollment
1
Location
14
Actual Duration (Months)
0.4
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The goal is to conduct a clinical pilot study to evaluate the use of a rotating multi-segment slant-hole collimator in the detection of myocardial defects.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Myocardial perfusion SPECT is recognized as an effective clinical diagnostic imaging technique in the assessment of myocardial perfusion and coronary artery diseases. It is the most important clinical application of SPECT imaging techniques.

    The goal is to conduct a clinical pilot study to evaluate the use of rotating multi-segment slant-hole (RMSSH) SPECT in the detection of myocardial defects especially in very sick patients in the nuclear medicine clinics, emergence room, and intensive care units. Comparison of the clinical utilities of the cardiac RMSSH SPECT technique with conventional cardiac planar and SPECT with parallel-hole collimation will also allow us to evaluate the potential application of the technique to a wider patient population.

    The objective of this study is to test the hypothesis that quantitative 99mTc myocardial perfusion RMSSH SPECT provides similar diagnostic accuracy in patients with cardiac diseases as conventional SPECT imaging techniques.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    5 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Myocardial Perfusion SPECT Using a Rotating Multi-segment Slant-hole Collimator
    Actual Study Start Date :
    Oct 1, 2006
    Actual Primary Completion Date :
    Dec 1, 2007
    Actual Study Completion Date :
    Dec 1, 2007

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      18 Years to 80 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • Males and Females 18-80 who are scheduled for a clinical Cardiac Stress Test
      Exclusion Criteria:
      • Pregnant Women and Children

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Johns Hopkins Outpatient Center Baltimore Maryland United States 21287

      Sponsors and Collaborators

      • Johns Hopkins University
      • National Institute for Biomedical Imaging and Bioengineering (NIBIB)

      Investigators

      • Principal Investigator: Benjamin Tsui, Ph.D., Johns Hopkins University

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Johns Hopkins University
      ClinicalTrials.gov Identifier:
      NCT00328315
      Other Study ID Numbers:
      • NO:05-06-03-02
      • R01 EB 0019-83
      First Posted:
      May 19, 2006
      Last Update Posted:
      Apr 6, 2018
      Last Verified:
      Apr 1, 2018
      Keywords provided by Johns Hopkins University
      Myocardial Perfusion SPECT
      Additional relevant MeSH terms:
      Coronary Artery Disease
      Chest Pain

      Study Results

      No Results Posted as of Apr 6, 2018